Published in Sci Rep on April 20, 2017
The language of covalent histone modifications. Nature (2000) 44.92
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell (2001) 11.39
Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell (2003) 11.33
Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem (2006) 8.66
Chronic obstructive pulmonary disease. N Engl J Med (2000) 8.23
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med (2005) 6.13
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest (2008) 3.90
Complex chronic comorbidities of COPD. Eur Respir J (2008) 3.84
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature (2007) 2.76
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52
SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49
Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A (2008) 2.33
Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev (2002) 2.10
Molecular mechanisms of corticosteroid resistance. Chest (2008) 2.06
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000) 2.02
The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.99
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 1.82
Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J Cell Sci (2000) 1.76
Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem (2007) 1.75
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet (2004) 1.71
An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature (2012) 1.60
Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc (2007) 1.45
Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection. Mol Cell (2011) 1.29
Constitutive heterochromatin formation and transcription in mammals. Epigenetics Chromatin (2015) 1.26
Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc Natl Acad Sci U S A (2013) 1.24
Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Hepatology (2012) 1.06
p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression. Oncogene (2013) 1.00
p53-mediated heterochromatin reorganization regulates its cell fate decisions. Nat Struct Mol Biol (2012) 1.00
Reduced nuclear factor-κB repressing factor: a link toward systemic inflammation in COPD. Eur Respir J (2012) 0.88
Identification of epipolythiodioxopiperazines HDN-1 and chaetocin as novel inhibitor of heat shock protein 90. Oncotarget (2015) 0.84
Gene polymorphisms and chronic obstructive pulmonary disease. J Cell Mol Med (2013) 0.81
Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Effects of size and surface of zinc oxide and aluminum-doped zinc oxide nanoparticles on cell viability inferred by proteomic analyses. Int J Nanomedicine (2014) 0.85
Characterization of aging-associated cardiac diastolic dysfunction. PLoS One (2014) 0.85
Characterization of pulmonary protein profiles in response to zinc oxide nanoparticles in mice: a 24-hour and 28-day follow-up study. Int J Nanomedicine (2015) 0.80
The association of annual air pollution exposure with blood pressure among patients with sleep-disordered breathing. Sci Total Environ (2015) 0.78
Protein oxidation and degradation caused by particulate matter. Sci Rep (2016) 0.77
Noncanonical NF-κB mediates the Suppressive Effect of Neutrophil Elastase on IL-8/CXCL8 by Inducing NKRF in Human Airway Smooth Muscle. Sci Rep (2017) 0.75
Interplay of Aging and Hypertension in Cardiac Remodeling: A Mathematical Geometric Model. PLoS One (2016) 0.75
Investigation into the pulmonary inflammopathology of exposure to nickel oxide nanoparticles in mice. Nanomedicine (2017) 0.75
Pulmonary exposure to metal fume particulate matter cause sleep disturbances in shipyard welders. Environ Pollut (2017) 0.75
Prediction of the severity of obstructive sleep apnea by anthropometric features via support vector machine. PLoS One (2017) 0.75
Corrigendum to "The association of annual air pollution exposure with blood pressure among patients with sleep-disordered breathing" [Sci. Total Environ. 543 (2016) 61-66]. Sci Total Environ (2017) 0.75